Clinical Trial: BOTOX® vs. XEOMIN® for Chronic Migraine
Study Status: Completed
Recruit Status: RECRUITING
Condition: Chronic Migraine
Study Type: INTERVENTIONAL
Official Title: Single Center Study on the Sustained Effect of OnabotulinumtoxinA (BOTOX®) vs. IncobotulinumtoxinA (XEOMIN®) Botulinum Toxin in Adults With Chronic Migraine
Brief Summary:
Chronic migraine (CM) is a disabling disorder that sidelines active duty personnel and diminishes their quality of life.It affects 1.3% to 2.4% of the general population.These numbers increase in active duty personnel, especially those returning from deployment, as well as in veterans.Furthermore, these numbers are 4-5 times higher in military members who experienced at least one mild traumatic brain injury.CM leads to impaired cognition and poor decision-making.These impairments on critical active duty tasks…
Read more